Fatores que interferem na sobrevivência de pacientes com marca-passo cardíaco artificial permanente

Sant'Anna, João Ricardo; Lucchese, Fernando Antonio; Kalil, R. A; Prates, Paulo R; Pereira, E; Tavares, C. E; Nesralla, Ivo Abrahäo.
Arq. bras. cardiol ; 42(5): 331-337, 1984. ilus, tab
Artículo en Portugués | LILACS | ID: lil-21246

Documentos relacionados

  1. Fluorinated steroids are not superior to any treatment to ameliorate the outcome of autoimmune mediated congenital heart block: a systematic review of the literature and meta-analysis.
  2. Temporary pacemaker implantation through umbilical vein in a low birth weight neonate with congenital complete heart block.
  3. [Detection and prevention of maternal autoantibody-related congenital heart block].
  4. Keeping upbeat to prevent the heartbreak of anti-Ro/SSA pregnancy.
  5. Placement of permanent pacemaker in a low-birth-weight infant with congenital heart block: a case report.
  6. Home monitoring of fetal heart rhythm: Lived experiences of women with anti-SSA/Ro52 autoantibodies and their co-parents.
  7. Severe cardiac conduction disease associated with titin gene mutation.
  8. Cohort study of congenital complete heart block among preterm neonates: a single-center experience over a 15-year period.
  9. Long-term physical and neurodevelopmental outcomes after antenatal betamethasone administration for congenital heart block prevention.
  10. Pacemaker implantation and mortality: no role as a quality control indicator: Author's reply.